|
|
Benchmark Studies
The benchmark studies below are part of our ongoing research and consulting. By participating in one of the following surveys, you will receive a free copy of the results in presentation format.
You can download free sample findings of previous Internet Benchmarking Exchange surveys, and find all previous results archived in the Best Practice Database.
Current Studies  |
Developing a Competitive Budget for a Successful U.S. Product Launch -
Survey Topic: Launch Costs
Intent of Survey: This benchmarking study investigates current investment levels for promotional, educational and market-access activities required to successfully launch a new drug into the U.S. market. Participants in this study will be able to use the research results to determine whether their own spending levels are competitive in today's fast-changing pharmaceutical marketplace.
Job Title(s) Requested to Participate: Pharma and biotech executives, directors and managers who have recent or current experience with U.S. launch (or launch preparation) of a new pharmaceutical product.
Expected Time Commitment: 20 minutes
Completion Target Date: Participant responses are requested by September 26, 2010 Begin The Survey
Best Practices in Utilizing Health Outcomes Data for Promotional/Commercial Efforts -
Survey Topic: Health Economics Outcomes Research
Intent of Survey: This benchmarking study seeks to understand how pharmaceutical and biotech companies optimize and utilize health outcomes data and any Regulatory issues that could arise as a result of this use
Job Title(s) Requested to Participate: Executives, directors, managers, or individuals at pharmaceutical and biotech organizations who work within or with Health Outcomes organizations.
Expected Time Commitment: minutes
Completion Target Date: Participant responses are requested by September 27, 2010 Begin The Survey
Update: Roles, Resourcing and Management of Medical Science Liaisons -
Survey Topic: Medical Science Liaisons
Intent of Survey: As competition for the time and attention of physicians, key opinion leaders and thought leaders intensifies, pharmaceutical companies are increasingly using field-based medical specialists (also called liaisons) to build and strengthen key relationships. This research seeks to uncover the optimal number of liaisons, mix of responsibilities, number of interactions and span of control.
Job Title(s) Requested to Participate: Pharmaceutical executives who are responsible for or involved with their company's field-based medical specialists or liaisons program are encouraged to participate.
Expected Time Commitment: 15 minutes
Completion Target Date: Participant responses are requested by October 17, 2010 Begin The Survey
|
|
|